Skip to content

To test the effectiveness of two drugs for spinal anaesthesia in below umbilical surgeries.

Evaluation of hyperbaric levobupivacaine (0.5%) and hyperbaric bupivacaine (0.5%) in patients undergoing infra-umbilical surgeries - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055159
Enrollment
60
Registered
2023-07-13
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: S318- Open wound of other parts of abdomen, lower back and pelvis

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age group 18-60 years of either age. 2) Patients with ASA grade I and II 3) patients with average height ( >5 feet). 4) All patients undergoing infra-umbilical surgeries

Exclusion criteria

Exclusion criteria: 1) Patient refusal or not giving consent. 2) Patients with the Neurological disease, bleeding diathesis, Coagulopathy disorders. 3) Patients with spine/Neurological deformities, 4) Local Skin infections or disease. 5) History of drug allergy. 6) Patients on tranquilizers, hypnotics, sedatives and other psychotropic drugs. 7) Severe liver or kidney diseases. 8) ASA grade III and IV, V.

Design outcomes

Primary

MeasureTime frame
To evaluate the effects of Hyperbaric Levobupivacaine (0.5%) & Hyperbaric Bupivacaine (0.5%) on the onset & duration of sensory and motor block and to evaluate perioperative hemodynamic effectsTimepoint: Immediately after induction till 180 minutes.

Secondary

MeasureTime frame
To evaluate the post-operative analgesia. To evaluate the occurrence of side effects & complications, if any. Timepoint: Immediately after induction till 180 minutes.

Countries

India

Contacts

Public ContactDr Rajni Thakur

Gandhi Medical College, Bhopal

drskraikwar@gmail.com8989118989

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026